Similarly, Kongensin A, has also been evaluated in vitro for inhibiting HSP90 and Cdc37 interaction, which prevents the RIP3-dependent necroptosis and activates apoptosis in various cancer cell lines. Here, HSP90AA1 is linked to cancer.